home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Crohn's Disease Genetics

 
  June, 1 2001 0:14
your information resource in human molecular genetics
 
     
Scientists in America and Europe have independently found a gene for Crohn’s disease, a debilitating inflammatory bowel disease affecting about one in every thousand people in Western countries (Nature, Vol. 411, No. 6837, 31 May 2001).

Crohn’s disease often affects young adults, and its incidence has increased greatly over the last 50 years, probably reflecting changes in the environment and lifestyles. Possibly as a result of faulty responses to microbes living in the gut, the immune system of a patient is triggered to attack the gut lining, causing it to ulcerate and break up. Crohn’s disease has complex genetic causes, but no major gene contributing to disease susceptibility or pathology has previously been identified. One susceptibility gene was mapped in 1996 to human chromosome 16.

Now, advances in molecular genetics and the availability of the human genome sequence have led to the identification of a gene that occurs on the previously implicated region on chromosome 16. This gene is mutated in a subset of patients with Crohn’s disease.

The gene encodes a protein called Nod2. Intriguingly, Nod2 is involved in the recognition of microbes and signalling events leading to an appropriate immune response. The mutations found in patients disrupt proper signalling, which suggests a close link between the immune response to gut microbes and the development of disease.

There is no single gene for Crohn’s disease, and not every person with mutations in the gene for Nod2 will be affected. Nevertheless, Nod2 does seem normally to protect against the disease, and mutations in the gene increase disease susceptibility. Restoration of proper Nod2 function in such individuals could represent a promising preventative therapy.

CONTACT:

Dr Gilles Thomas
Fondation Jean Dausset CEPH
Paris, France
Tel +33 6 08 98 22 00
E-mail Thomas@cephb.fr

Dr Gabriel Nunez
University of Michigan Medical School
Ann Arbor, Michigan, USA
Tel +1 734 764 8514
E-mail Bclx@umich.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.